UBI Ubisoft Entertainment SA

Ubisoft Announces its Global Creative Office

Ubisoft Announces its Global Creative Office

  
 
Ubisoft Announces its Global Creative Office



The new organization aims to further grow the value of Ubisoft’s brands by boosting game creation, delivery and fostering the autonomy of creative teams in studios
 



 







 
PARIS – October 6, 2022 – Today, Ubisoft is announcing the implementation of its Global Creative Office to better reflect and support its portfolio strategy. With this evolution, Ubisoft aims to further support creative teams by facilitating decision-making and strengthening the responsibility and autonomy of studios throughout the creative process. The overall goal is to boost creativity and ensure the highest level of quality in the execution and delivery of Ubisoft's games.



 



The new Creative Office will be structured around poles, moving away from a centralized organization to better support the key segments of Ubisoft’s portfolio strategy. Building on the Group’s vision, each pole will leverage its expertise to dive into the specificities of its audiences, game design and tech.



 



Chief Creative Officer Igor Manceau, who was instrumental in refining the group’s creative vision and in laying the foundations of this new organization, will leave Ubisoft for personal reasons at the end of November. In the meantime, Igor will continue refining the structure, in close collaboration with Marie-Sophie de Waubert, SVP of Studios, Martin Schelling, SVP of Production, Sandrine Caloiaro, Chief Portfolio Officer, Guillemette Picard, SVP of Production Technology and studio Managing Directors. Following Igor’s departure, Marie-Sophie will temporarily take over management of the Creative Office to ensure a smooth transition across teams and projects.



 



“In a fast-moving industry, it’s essential that we continue to adapt. I am grateful for Igor’s contribution to refining Ubisoft’s creative approach and for his commitment to bringing fresh ideas that level up the way we create,” said Yves Guillemot, CEO and Co-Founder, Ubisoft. “An exemplary leader, Igor has set the foundations for a new organization that will allow Ubisoft to successfully deliver on its content strategy, with new processes and clearer roles and responsibilities.”



 



"Over the last 24 years I got the chance to meet and work with talented and inspiring teams around the world. I am grateful for the opportunity to have taken part in this fantastic adventure.” Said Manceau. “I am confident in Ubisoft’s potential to continue surprising and delighting players for years to come”.

  

# # #

Contacts

Investor Relations

Jean-Benoît Roquette

SVP Investor Relations

39

Press Relations

Fabien Darrigues

Director of Global Communications

   

Alexandre Enjalbert

Senior Investor Relations Manager

78

About Ubisoft

Ubisoft is a creator of worlds, committed to enriching players’ lives with original and memorable entertainment experiences. Ubisoft’s global teams create and develop a deep and diverse portfolio of games, featuring brands such as Assassin’s Creed®, Brawlhalla®, For Honor®, Far Cry®, Tom Clancy’s Ghost Recon®, Just Dance®, Rabbids®, Tom Clancy’s Rainbow Six®, The Crew®, Tom Clancy’s The Division®, and Watch Dogs®. Through Ubisoft Connect, players can enjoy an ecosystem of services to enhance their gaming experience, get rewards and connect with friends across platforms. With Ubisoft+, the subscription service, they can access a growing catalog of more than 100 Ubisoft games and DLC. For the 2021–22 fiscal year, Ubisoft generated net bookings of €2,129 million. To learn more, please visit:

© 2022 Ubisoft Entertainment. All Rights Reserved. Ubisoft and the Ubisoft logo are registered trademarks in the US and/or other countries.

 

Attachment



EN
06/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ubisoft Entertainment SA

Ubisoft Entertainment: 1 director

A director at Ubisoft Entertainment bought 100,000 shares at 4.624EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

 PRESS RELEASE

Information sur les droits de vote et les actions au 31 mars 2026

Information sur les droits de vote et les actions au 31 mars 2026  Le 8 avril 2026 Information relative au nombre total de droits de vote et d’actions composant le capital social Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext Paris Compartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Information mensuelle au 31 mars 2026(Articles L. 233-8, II, du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers) DateNombre total d’actions composant le capital so...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NKTR NEKTAR THERAPEUTICS
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
ACRS ACLARIS THERAPEUTICS INC.
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ORIC KEROS THERAPEUTICS
ZNTL ORIC PHARMACEUTICALS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
SANA VIRIDIAN THERAPEUTICS INC
PLTK SANA BIOTECHNOLOGY
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
PEPG TYRA BIOSCIENCES INC
EWTX PEPGEN INC
SLDB EDGEWISE THERAPEUTICS INC
DDI SOLID BIOSCIENCES INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B APOGEE THERAPEUTICS INC
DNTH EMBRACER GROUP AB
ORKA DIANTHUS THERAPEUTICS INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
IMA JADE BIOSCIENCES INC
IMAGENEBIO INC.
 PRESS RELEASE

Ubisoft Appoints New Leaders to Advance Its Creative Houses Operating ...

Ubisoft Appoints New Leaders to Advance Its Creative Houses Operating Model     PRESS RELEASE       Ubisoft Appoints New Leaders to Advance Its Creative Houses Operating ModelJulien Bares named General Manager of Creative Houses 3 and 5; Thomas Andrén named General Manager of the Creative Network PARIS – MARCH 17, 2026 – Today Ubisoft announced new leadership appointments supporting the rollout of its Creative Houses-led operating model, marking an important step in the company’s ongoing transformation. Julien Bares will join Ubisoft as General Manager of Creative Houses 3, focused on high...

 PRESS RELEASE

Ubisoft nomme de nouveaux dirigeants et poursuit la mise en place de s...

Ubisoft nomme de nouveaux dirigeants et poursuit la mise en place de son nouveau modèle opérationnel, fondé sur les Maisons de Création     COMMUNIQUÉ DE PRESSE        Ubisoft nomme de nouveaux dirigeants et poursuit la mise en place de son nouveau modèle opérationnel, fondé sur les Maisons de Création Julien Bares nommé General Manager des Maisons de Création 3 et 5 ; Thomas Andrén nommé General Manager du Creative Network PARIS – 17 MARS 2026 – Ubisoft annonce aujourd’hui de nouvelles nominations au sein de sa direction afin d’accélérer le déploiement du modèle opérationnel de ses Mai...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch